SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients

• Liane M. McGlynn,

  Affiliation Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Simon McCluney,

  Affiliation Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Nigel B. Jamieson,

  Affiliations West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom, Academic Department of Surgery, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Jackie Thomson,

  Affiliation Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Alasdair I. MacDonald,

  Affiliation Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Karin Oien,

  Affiliation Institute of Cancer Sciences, Pathology, Wolfson Building, Beatson Labs, Glasgow, United Kingdom

  ⨯
• Euan J. Dickson,

  Affiliation West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom

  ⨯
• C. Ross Carter,

  Affiliation West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom

  ⨯
• Colin J. McKay,

  Affiliation West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom

  ⨯
• Paul G. Shiels

  * E-mail: paul.shiels@glasgow.ac.uk

  Affiliation Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯